TMN355
CAS No. 1186372-20-2
TMN355( —— )
Catalog No. M22935 CAS No. 1186372-20-2
TMN355 is a potent chemical inhibitor of cyclophilin A and reduces foam cell formation and cytokine secretion,and is used for atherosclerosis. Silencing cyclophilin A in THP-1 cells and human monocytes using siRNA or chemical inhibitor, TMN355 resulted in decrease in lipid uptake by 65-75% even after exposure to oxidized LDL.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 132 | In Stock |
|
| 10MG | 205 | In Stock |
|
| 25MG | 357 | In Stock |
|
| 50MG | 554 | In Stock |
|
| 100MG | 788 | In Stock |
|
| 500MG | 1602 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTMN355
-
NoteResearch use only, not for human use.
-
Brief DescriptionTMN355 is a potent chemical inhibitor of cyclophilin A and reduces foam cell formation and cytokine secretion,and is used for atherosclerosis. Silencing cyclophilin A in THP-1 cells and human monocytes using siRNA or chemical inhibitor, TMN355 resulted in decrease in lipid uptake by 65-75% even after exposure to oxidized LDL.
-
DescriptionTMN355 is a potent chemical inhibitor of cyclophilin A and reduces foam cell formation and cytokine secretion,and is used for atherosclerosis. Silencing cyclophilin A in THP-1 cells and human monocytes using siRNA or chemical inhibitor, TMN355 resulted in decrease in lipid uptake by 65-75% even after exposure to oxidized LDL.?The expression of scavenger receptors expressed during differentiation process, CD36 and LOX-1 were decreased (p 0.0001).?Levels of extracellular cyclophilin A and other inflammatory cytokines such as TNF-α and MCP-1also significantly reduced.?TMN 355 (0.5-10 μM;?3-9 hours) results in 75.9% reduction of cyclophilin A protein expression.?And cyclophilin A after 6 h of activation inhibited by TMN 355(1 μM).
-
In VitroTMN 355 (0.5-10 μM; 3-9 hours) results in 75.9% reduction of cyclophilin A protein expression. And 1 μM TMN 355 inhibits cyclophilin A after 6 h of activation.Western Blot Analysis Cell Line:THP cell lines Concentration:0.5, 1, 2.5, 5 and 10 μM Incubation Time:3, 6 and 9 hours Result:Resulted in 75.9% reduction of cyclophilin A protein expression.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptorcyclophilin A
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1186372-20-2
-
Formula Weight380.8
-
Molecular FormulaC21H14ClFN2O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:31.25 mg/mL (82.06 mM; Need ultrasonic)
-
SMILESO=C(NC(NC1C2=C(C3=C1C=CC=C3)C=CC=C2)=O)C4=C(F)C=CC=C4Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ramachandran S, et al. Cyclophilin A enhances macrophage differentiation and lipid uptake in high glucose conditions: a cellular mechanism for accelerated macro vascular disease in diabetes mellitus. Cardiovasc Diabetol. 2016 Nov 3;15(1):152.
molnova catalog
related products
-
Ethyleneurea
2-Imidazolidinone is used as a formaldehyde scavenger and intermediate.
-
ISOTHIAZOLINE 1,1-DI...
ISOTHIAZOLINE 1,1-DIOXIDE is a reactant used in the synthesis of orally bioavailable hebatits B caspid inhibitors, and in the preparation of cryptochrome imhibitors as antidiabetic agents.
-
Eflucimibe
Eflucimibe (L0081) is an acyl coenzyme A: cholesterol acyltransferase inhibitor for the treatment of cardiovascular disease and endocrine and metabolic disorders, and can be used to study atherosclerosis and hyperlipidemia.
Cart
sales@molnova.com